FTUS
AZN icon

Flow Traders U.S.’s AstraZeneca AZN Stock Holding History

Flow Traders U.S.’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,797
Closed -$2.54M – 1002
2025
Q4 		$2.54M Buy
+13,797
New +$2.42M 0.08% 151
2025
Q1 		– Sell
-4,146
Closed -$543K – 924
2024
Q4 		$543K Buy
+4,146
New +$580K 0.02% 570
2024
Q3 		– Sell
-19,235
Closed -$3M – 872
2024
Q2 		$3M Buy
19,235
+14,804
+334% +$2.23M 0.15% 119
2024
Q1 		$600K Buy
4,431
+1,806
+69% +$239K 0.03% 431
2023
Q4 		$354K Buy
+2,625
New +$341K 0.01% 572
2022
Q3 		– Sell
-1,517
Closed -$200K – 1009
2022
Q2 		$200K Sell
1,517
-53
-3% -$6.95K 0.01% 704
2022
Q1 		$208K Sell
1,570
-3,080
-66% -$369K 0.01% 736
2021
Q4 		$542K Buy
+4,650
New +$547K 0.03% 445
2019
Q3 		– Sell
-3,000
Closed -$248K – 330
2019
Q2 		$248K Buy
3,000
+522
+21% +$40.9K 0.02% 249
2019
Q1 		$200K Buy
+2,478
New +$195K 0.01% 297
2015
Q2 		– Sell
-1,100
Closed -$75K – 189
2015
Q1 		$75K Hold
1,100
– – 0.02% 110
2014
Q4 		$77K Sell
1,100
-400
-27% -$28.6K 0.01% 135
2014
Q3 		$107K Buy
+1,500
New +$110K 0.01% 115
2013
Q4 		– Sell
-12,624
Closed -$655K – 193
2013
Q3 		$655K Buy
+12,624
New +$634K 0.1% 78

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Flow Traders U.S.'s AZN Position: Q1 2026 in Review

Flow Traders U.S. sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 13,797 shares — an estimated $2.54M sold.

Flow Traders U.S. first reported a position in AZN in Q3 2013 and held it in 14 quarters. The position peaked at $3M in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Flow Traders U.S. reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Flow Traders U.S. sold 13,797 AstraZeneca shares in Q1 2026, an estimated $2.54M.
  • Flow Traders U.S. first reported a position in AstraZeneca in Q3 2013 and held it in 14 quarters.
  • Flow Traders U.S.'s AstraZeneca position peaked at $3M in Q2 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.